Salicylate Downregulates 11β-HSD1 Expression in Adipose Tissue in Obese Mice and in Humans, Mediating Insulin Sensitization

Recent trials show salicylates improve glycemic control in type 2 diabetes, but the mechanism is poorly understood. Expression of the glucocorticoid-generating enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) in adipose tissue is increased in vitro by proinflammatory cytokines and upregulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Mark, Wake, Deborah J., Livingstone, Dawn E., Stimson, Roland H., Esteves, Cristina L., Seckl, Jonathan R., Chapman, Karen E., Andrew, Ruth, Walker, Brian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314355/
https://www.ncbi.nlm.nih.gov/pubmed/22357964
http://dx.doi.org/10.2337/db11-0931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314355/
https://www.ncbi.nlm.nih.gov/pubmed/22357964
http://dx.doi.org/10.2337/db11-0931

Ejemplares similares